Advertisement

Topics

Company Under Fire for Opioid Marketing Files Patent Suit

06:15 EDT 15 Sep 2017 | PharmPro

Insys Therapeutics filed a complaint in federal court against Teva Pharmaceuticals alleging that Teva intends to manufacture and sell a generic version of a fentanyl oral spray before Insys patents expire.
Contributed Author: 
Randall Chase, AP Business Writer
Topics: 

Original Article: Company Under Fire for Opioid Marketing Files Patent Suit

NEXT ARTICLE

More From BioPortfolio on "Company Under Fire for Opioid Marketing Files Patent Suit"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...